Randomized double‐blind cross‐over trial of bath additive containing tannic acid in patients with atopic dermatitis

• Egile Nagusiak: Shunsuke Takahagi (Egilea), Naoe Harada (Egilea), Akiko Kamegashira (Egilea), Shigeru Suzuki (Egilea), Hajime Shindo (Egilea), Hirotoshi Kanatani (Egilea), Akio Tanaka (Egilea), Hayato Mizuno (Egilea), Michihiro Hide (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2020-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Skin care against aggravating factors is important to prevent skin lesions from flare‐up in the treatment of atopic dermatitis (AD). Tannic acid (TA), a natural polyphenolic and protein‐denaturing agent, has activity to denature antigens relevant to the AD flare. To assess the efficacy of a...